


Funding Circle reported H1 2026 revenue of ~£138m (+50% y/y) and profit before tax of ~£23m vs ~£6m in H1 2025, with credit extended of £1.7bn and AuM rising to £3.3bn. Cash increased to £136m at 30 June 2026 (from £101m at 31 Dec), supported by cash generation and monetisation of its shorter-term loan portfolio. The company reiterated FY2026 guidance of at least £235m revenue and at least £35m profit before tax and disclosed continued capital returns via a share buyback program (18% of issued share capital bought back; £72m to date).
The key signal is not the headline growth rate but the step-change in funding quality and per-share economics. A business that can turn loan origination into cash quickly, while simultaneously retiring stock, deserves a materially lower cost of equity than a typical fintech lender; that is the mechanism for multiple expansion here. The second-order effect is that stronger cash generation can be recycled into adjacent products, which should let the company take share in SME working capital spend without leaning harder on external capital.
Near term, the market should focus on whether the apparent operating leverage is sustainable after the seasonal slowdown and whether H2 credit performance lags the H1 profitability. The first place this can break is not revenue, but net loss assumptions: SME credit tends to look best just before delinquencies show up, so a few months of smooth prints do not eliminate downside if the UK macro softens. For the next 1-3 months, the interim update is the main catalyst; if impairments or origination momentum disappoint, the stock can give back a meaningful portion of the rerating quickly.
The contrarian view is that investors may be underestimating how much of the current story is already in the price after the buyback and cash-flow narrative. If management proves that FlexiPay/Card growth is still being funded without compromising credit discipline, the move can extend for 6-18 months as the market re-rates it from a cyclical lender to a capital-efficient compounder. The falsifier is straightforward: any evidence that growth is being bought with looser underwriting, rising funding costs, or a cut to FY26 guidance would invalidate the bullish case.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
strongly positive
Sentiment Score
0.70
Ticker Sentiment